An oral androgen receptor RIPTAC for prostate cancer.

Abstract Poster

Authors

null

Kanak Raina

Halda Therapeutics, New Haven, CT

Kanak Raina , Kyle J Eastman , Xinheng Yu , Chris D Forbes , Kelli M Jones , James J Mousseau , Hao Li , Katherine J Kayser-Bricker , Craig M Crews

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 184)

DOI

10.1200/JCO.2023.41.6_suppl.184

Abstract #

184

Poster Bd #

G2

Abstract Disclosures

Similar Posters

Poster

2018 Genitourinary Cancers Symposium

An oral androgen receptor PROTAC degrader for prostate cancer.

An oral androgen receptor PROTAC degrader for prostate cancer.

First Author: Taavi Neklesa

First Author: Michael Thomas Schweizer

First Author: Jordan Vellky

First Author: Siyuan S Guo